Hepion Pharms Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,404 | 5,957 | 9,832 | 1,791 | 4,563 |
| TOTAL | $7,895 | $6,626 | $10,518 | $2,720 | $5,244 |
| Non-Current Assets | |||||
| PPE Net | 81 | 72 | 77 | 83 | 81 |
| Intangibles | 1,871 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,260 | 51 | 51 | 51 | 51 |
| TOTAL | $5,212 | $123 | $129 | $134 | $133 |
| Total Assets | $13,107 | $6,750 | $10,646 | $2,854 | $5,377 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,252 | 3,441 | 3,162 | 3,196 | 1,481 |
| Accrued Expenses | 821 | 847 | 599 | 1,019 | 457 |
| TOTAL | $5,084 | $4,289 | $3,761 | $4,215 | $1,938 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,436 | 1,166 | 1,901 | 0 | 0 |
| TOTAL | $6,706 | $1,166 | $1,901 | $N/A | $N/A |
| Total Liabilities | $11,789 | $5,454 | $5,662 | $4,215 | $1,938 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 32,231 | 27,295 | 27,295 | N/A |
| Common Shares | 3 | 3 | 3 | 2 | 2 |
| Retained earnings | -44,613 | -39,406 | -35,489 | -32,458 | -27,614 |
| Other shareholders' equity | 13,700 | 13,700 | 13,700 | 13,700 | 13,700 |
| TOTAL | $1,318 | $1,295 | $4,984 | $-1,361 | $3,439 |
| Total Liabilities And Equity | $13,107 | $6,750 | $10,646 | $2,854 | $5,377 |